SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The sharp rally has no confirmed company-news catalyst; traders are focused on anticipation of the REGAL Phase 3 final analysis, which is triggered at 80 survival events after the last disclosed count of 78. Some interpret the CEOs anniversary message and SELLASs planned ASH presence as signs of a potential buyout, while others call that speculation and see the move as a rebound or possible short covering.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is being attributed by traders to possible short covering and anticipation of upcoming DM1 and FSHD siRNA data, with Arrowheads RNAi results cited as supportive context. No new Sarepta catalyst is confirmed in the discussion, and some traders view the move as technical or part of broader biotech strength.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is drawing attention amid a steep selloff in AI-data-center and neocloud stocks, as traders debate financing risks and whether sector-wide concerns apply to the company. Co-CEO Daniel Roberts comments that data centers were built with cash and customer prepayments help fund GPU costs have reassured some bulls, while others remain concerned about dilution, execution and IRENs weak performance versus peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new share-repurchase authorization are being overshadowed by a narrowed full-year profit outlook whose midpoint was unchanged, prompting a sharp selloff. Traders are split between viewing the buyback and stronger cash-flow outlook as support and seeing cautious guidance, lower U.S. sales, and cost pressures as reasons for the decline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas volatile pullback and bounce amid broader crypto weakness are driving discussion, with traders watching support and Bitcoins direction. Dip-buyers are accumulating and staking, while bearish traders warn the recovery may fail and expect further downside.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention ahead of its Q3 earnings report, with traders watching whether ASCENIVs growth can offset continued weakness in BIVIGAM and restore confidence in the companys outlook. Some point to improving share-price momentum and buybacks, while others remain cautious because of the earlier short-seller allegations and questions about growth visibility.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports RAP-219 Phase 2 trial in bipolar mania met its primary and secondary endpoints, fueling buying interest and analyst optimism. Traders are debating whether the efficacy signal is strong enough given the modest placebo-adjusted improvement, higher discontinuation rates, and safety questions, contributing to volatile trading.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash transaction as a potential balance-sheet and strategic reset. Bulls welcome the deal and momentum, while skeptics argue the sale removes a revenue-generating business and leaves concerns about declining operations and debt; the transaction remains subject to approval.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2026 results after the market closes on Wednesday, Nov. 4, 2026. A conference call will be held the following day, Thursday, Nov...

The University of Kansas Health System and Ardent Health Announce Plans to Transition Ownership of St. Francis Campus

The University of Kansas Health System and Ardent Health (NYSE: ARDT) announced the signing of a definitive agreement today for The University of Kansas Health System to acquire full ownership of St. Francis Campus and affiliated care locations in Topeka, following a successful joint venture...

Is the Options Market Predicting a Spike in Ardent Health Stock?

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Ardent Health Hospitals Earn Recognition in U.S. News & World Reports 2026-2027 Best Hospitals Rankings

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that 13 hospitals across its network earned recognition in U.S. News & World Reports 2026-2027 Best Hospitals rankings, the publications 37th annual assessment of...

HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)

HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today defined the Enterprise Clinical Workforce Platform (ECWP), establishing a new enterprise category for healthcare built on a single, verified record for every clinician. For decades...

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler the first time...

Tuesday Sector Leaders: Hospital & Medical Practitioners, Cigarettes & Tobacco Stocks

In trading on Tuesday, hospital & medical practitioners shares were relative leaders, up on the day by about 1.8%. Leading the group were shares of Surgery Partners, up about 6.2% and shares of Ardent Health up about 3.8% on the day.

Also showing relative strength are ciga...

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the...

Implied Volatility Surging for Ardent Health Stock Options

Investors need to pay close attention to ARDT stock based on the movements in the options market lately. 

Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region

Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials and recently became the first in the United States to use the...

Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.

Ardent Health Inc.

US Election 2024: BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump Win

Equity

Neutral Sentiment

Following Donald Trump’s election win, Bank of America (BoFA)&nbsp;Securities updated its ratings on several healthcare stocks, according to thefly.com, indicating a mixed outlook for the sector under the new administration.&nbsp;Trump’s policies are anticipated to reshape healthcare, potentially easing regulatory pressures on Medicare Advantage providers like Humana, while casting uncertainties on other healthcare areas.THE UPSIDEBoFA&nbsp;Securities upgraded Humana (<a class="mention" data-mention="$HUM" data-symbol-id="HUM" href="https://stocktwits.com/symbol/HUM" target="_blank">$HUM</a>) from ‘Underperform’ to ‘Neutral,’ raising its price target from $247 to $308. Analysts see “dramatically improved” risk-reward dynamics for Humana, driven by potential for stronger reimbursement rates and diminished scrutiny on quality ratings and antitrust issues.&nbsp;These factors could offer a pathway for stock appreciation, particularly as regulatory pressures ease.&nbsp;Speculation is also mounting regarding a possible acquisition by Cigna ($CI) — rumored to be in pursuit of Humana.&nbsp;With anticipated softer antitrust oversight under a Trump-led administration, BoFA suggests the likelihood of an acquisition has increased, providing additional valuation support for HUM.&nbsp;Humana shares surged nearly 10% by Wednesday afternoon, with Stocktwits retail sentiment holding steady at ‘neutral.’<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/HUM_sentiment_and_message_volume_Nov_6_4fa9591bab.png" alt="HUM sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>HUM sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>STAYING CAUTIOUSBoFA downgraded Universal Health Services (<a class="mention" data-mention="$UHS" data-symbol-id="UHS" href="https://stocktwits.com/symbol/UHS" target="_blank">$UHS</a>) and Ardent Health Services (<a class="mention" data-mention="$ARDT" data-symbol-id="ARDT" href="https://stocktwits.com/symbol/ARDT" target="_blank">$ARDT</a>) to ‘Neutral’ from ‘Buy,’ citing concerns about the impact of Trump’s win on Medicaid supplemental payments and health exchanges.&nbsp;The brokerage slashed UHS’s target from $259 to $223 and ARDT’s from $22 to $19, suggesting the current healthcare environment could become unfavorable for hospitals and healthcare facilities.&nbsp;UHS fell over 4% in Wednesday afternoon trading with retail sentiment at ‘neutral,’ while ARDT dropped more than 9% with retail sentiment marked as ‘extremely bullish.’<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/UHS_sentiment_and_message_volume_Nov_6_e469989915.png" alt="UHS sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>UHS sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure><figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ARDT_sentiment_and_message_volume_Nov_6_727743fabb.png" alt="ARDT sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>ARDT sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>RED FLAG?On Oscar Health (<a class="mention" data-mention="$OSCR" data-symbol-id="OSCR" href="https://stocktwits.com/symbol/OSCR" target="_blank">$OSCR</a>), BoFA downgraded the stock to ‘Underperform’ from ‘Neutral,’ lowering its price target from $21 to $13.50.&nbsp;BoFA argues that the Trump administration’s stance will likely result in reduced support for exchange subsidies — the financial assistance provided to individuals and families who purchase health insurance through the Affordable Care Act (ACA) — creating significant headwinds for Oscar Health.&nbsp;Lowering its 2027 EPS estimate by to $0.85 (60% below consensus), BoFA foresees valuation pressure as Congress revisits subsidy policies and as enrollment peaks in 2026.&nbsp;The brokerage sees some near-term strength on quarterly results but “expects valuation to be capped as one approaches the subsidy debate in congress and enrollment cliff in 2026.”OSCR shares plummeted over 14% Wednesday, with retail sentiment plunging to ‘extremely bearish’ — the lowest level recorded this year.<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/OSCR_sentiment_and_message_volume_Nov_6_ce215fc2e9.png" alt="OSCR sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>OSCR sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-election-2024-why-bank-stocks-are-rising-after-trump-victory/cJ4RCBjR9x">US Election 2024: Here’s Why Bank Stocks Are Rising After Trump's Victory</a>

BoFA downgraded Universal Health Services ($UHS) and Ardent Health Services ($ARDT) to ‘Neutral’ from ‘Buy,’ citing concerns about the impact of Trump’s win on Medicaid supplemental payments and health exchanges.

While Trump’s stance may benefit Medicare providers by pushing for higher rates and easing regulatory scrutiny, hospital operators face a challenging landscape under his proposed policies.

BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump Win: Are Retail Investors On Board?

Ardent Health Partners

Humana Inc

Oscar Health Inc - Ordinary Shares - Class A

Universal Health Services, Inc. - Ordinary Shares - Class B

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDT Ardent Health Partners

Fundamentals

Latest ARDT News